Correlation between genetic polymorphisms within IL-1B and TLR4 genes and cancer risk in a Russian population: A case-control study

Tumor Biology

Volumn 35, Issue 5, 2014, Pages 4821-4830

  Kutikhin, Anton G ^a,b   Yuzhalin, Arseniy E ^c   Volkov, Alexey N ^b,e   Zhivotovskiy, Alexey S ^d   Brusina, Elena B ^b  

^a RESEARCH INSTITUTE FOR COMPLEX ISSUES OF CARDIOVASCULAR DISEASES   (Russian Federation)

^b KEMEROVO STATE MEDICAL UNIVERSITY   (Russian Federation)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d Kemerovo Regional Clinical Oncological Dispensary   (Russian Federation)

^e KEMEROVO STATE UNIVERSITY   (Russian Federation)

Author keywords

Cancer; Interleukin; Single nucleotide polymorphism; Superoxide dismutase; Toll like receptor

Indexed keywords

INTERLEUKIN 1BETA; TOLL LIKE RECEPTOR 4; TLR4 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVARY CANCER; PRIORITY JOURNAL; RUSSIAN FEDERATION; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CARCINOMA; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; NEOPLASM; OVARY TUMOR; RECTUM TUMOR; RISK; STOMACH TUMOR;

AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; NEOPLASMS; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECTAL NEOPLASMS; RISK; RUSSIA; STOMACH NEOPLASMS; TOLL-LIKE RECEPTOR 4;

EID: 84902996977     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1633-6     Document Type: Article

References (43)

1. GWAS O b. Editorial. Nat Gen. 2010;42(7):551.
2. Zineh I, Huang SM. Biomarkers in drug development and regulation: a paradigm for clinical implementation of personalized medicine. Biomark Med. 2011;5(6):705-13.
3. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1893-907.
4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
5. Yuzhalin AE, Kutikhin AG. Integrative systems of genomic risk markers for cancer and other diseases: future of predictive medicine. Cancer Manag Res. 2012;4:131-5.
6. Kutikhin AG, Yuzhalin AE. Inherited variation in pattern recognition receptors and cancer: dangerous liaisons? Cancer Manag Res. 2012;4:31-8.
7. Zhang K, Zhou B, Wang Y, Rao L, Zhang L. The TLR4 gene polymorphisms and susceptibility to cancer: a systematic review and meta-analysis. Eur J Cancer. 2013;49(4):946-54.
8. Kutikhin AG, Yuzhalin AE. C-type lectin receptors and RIG-I-like receptors: new points on the oncogenomics map. Cancer Manag Res. 2012;4:39-53.
9. Kutikhin AG. Association of polymorphisms in TLR genes and in genes of the Toll-like receptor signaling pathway with cancer risk. Hum Immunol. 2011;72(11):1095-116.
10. Qidwai T, Khan F. Tumour necrosis factor gene polymorphism and disease prevalence. Scand J Immunol. 2011;74(6):522-47.
11. Peleteiro B, Lunet N, Carrilho C, Durães C, Machado JC, La Vecchia C, et al. Association between cytokine gene polymorphisms and gastric precancerous lesions: systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;19(3):762-76.
12. Mi YY, Yu QQ, Yu ML, Xu B, Zhang LF, Cheng W, et al. Review and pooled analysis of studies on -607(C/A) and -137(G/C) polymorphisms in IL-18 and cancer risk. Med Oncol. 2011;28(4):1107-15.
13. Persson C, Canedo P, Machado JC, El-Omar EM, Forman D. Polymorphisms in inflammatory response genes and their association with gastric cancer: a HuGE systematic review and meta-analyses. Am J Epidemiol. 2011;173(3):259-70.
14. Yuzhalin AE, Kutikhin AG. Common genetic variants in the myeloperoxidase and paraoxonase genes and the related cancer risk: a review. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2012;30(4):287-322.
15. Crawford A, Fassett RG, Geraghty DP, Kunde DA, Ball MJ, Robertson IK, et al. Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease. Gene. 2012;501(2):89-103.
16. Bag A, Bag N. Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: a review. Cancer Epidemiol Biomarkers Prev. 2008;17(12):3298-305.
17. Basith S, Manavalan B, Yoo TH, Kim SG, Choi S. Roles of toll-like receptors in cancer: a double-edged sword for defense and offense. Arch Pharm Res. 2012;35(8):1297-316.
18. Kutikhin AG, Yuzhalin AE. Are Toll-like receptor gene polymorphisms associated with, prostate cancer? Cancer Manag Res. 2012;4:23-9.
19. Hoyer KK, Dooms H, Barron L, Abbas AK. Interleukin-2 in the development and control of inflammatory disease. Immunol Rev. 2008;226:19-28.
20. Yuzhalin A. The role of interleukin DNA polymorphisms in gastric cancer. Hum Immunol. 2011;72(11):1128-36.
21. Howell WM, Rose-Zerilli MJ. Cytokine gene polymorphisms, cancer susceptibility, and prognosis. J Nutr. 2007;137(1 Suppl):194S-9S. (Pubitemid 46052880)
22. Yuzhalin AE, Kutikhin AG. Interleukin-12: clinical usage and molecular markers of cancer susceptibility. Growth Factors. 2012;30(3):176-91.
23. González CA, Sala N, Capellá G. Genetic susceptibility and gastric cancer risk. Int J Cancer. 2002;100(3):249-60. (Pubitemid 34728981)
24. Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev. 2008;226:205-18.
25. Milani P, Gagliardi S, Cova E, Cereda C. SOD1 transcriptional and posttranscriptional regulation and its potential implications in ALS. Neurol Res Int. 2011;2011:458427.
26. Monari M, Trinchero A, Calabrese C, Cattani O, Serrazanetti GP, Foschi J, et al. Superoxide dismutase in gastric adenocarcinoma: is it a clinical biomarker in the development of cancer? Biomarkers. 2006;11(6):574-84. (Pubitemid 44614828)
27. Yuzhalin AE, Kutikhin AG. Inherited variations in the SOD and GPX gene families and cancer risk. Free Radic Res. 2012;46(5):581-99.
28. Kamatani T, Yamamoto T, Yoneda K, Osaki T. Polymorphic mutations of the Mn-SOD gene in intact human lymphocytes and oral squamous cell carcinoma cell lines. Biochem Cell Biol. 2003;81(1):43-50. (Pubitemid 36523659)
29. Quan Y, Zhou B, Wang Y, Duan R, Wang K, Gao Q, et al. Association between IL17 polymorphisms and risk of cervical cancer in Chinese women. Clin Dev Immunol. 2012;2012:258-93.
30. Lee KA, Ki CS, Kim HJ, Sohn KM, Kim JW, Kang WK, et al. Novel interleukin 1beta polymorphism increased the risk of gastric cancer in a Korean population. J Gastroenterol. 2004;39(5):429-33. (Pubitemid 38811725)
31. Wang L, Jiang Y, Zhang Y, Wang Y, Huang S, Wang Z, et al. Association analysis of IL-17A and IL-17 F polymorphisms in Chinese Han women with breast cancer. PLoS One. 2012;7(3):e34400.
32. Shibata T, Tahara T, Hirata I, Arisawa T. Genetic polymorphism of interleukin-17A and -17F genes in gastric carcinogenesis. Hum Immunol. 2009;70(7):547-51.
33. Wang MH, Helzlsouer KJ, Smith MW, Hoffman-Bolton JA, Clipp SL, Grinberg V, et al. Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II. Prostate. 2009;69(8):874-85.
34. Yi JF, Li YM, Liu T, He WT, Li X, Zhou WC, et al. Mn-SOD and CuZn-SOD polymorphisms and interactions with risk factors in gastric cancer. World J Gastroenterol. 2010;16(37):4738-46.
35. Chomczynski P, Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc. 2006;1(2):581-5.
36. He J, Qiu LX, Wang MY, Hua RX, Zhang RX, Yu HP, et al. Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations. Hum Genet. 2012;131(7):1235-44.
37. Solé X, Guinó E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006;22(15):1928-9. (Pubitemid 44283043)
38. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B. 1995;57:289-300.
39. Agarwal A, Agrawal U, Verma S, Mohanty NK, Saxena S. Serum Th1 and Th2 cytokine balance in patients of superficial transitional cell carcinoma of bladder pre- and post-intravesical combination immunotherapy. Immunopharmacol Immunotoxicol. 2010;32(2):348-56.
40. Kemik O, Kemik AS, Begenik H, Erdur FM, Emre H, Sumer A, et al. The relationship among acute-phase response proteins, cytokines, and hormones in various gastrointestinal cancer types patients with cachectic. Hum Exp Toxicol. 2012;31(2):117-25.
41. Dwivedi S, Goel A, Natu SM, Mandhani A, Khattri S, Pant KK. Diagnostic and prognostic significance of prostate specific antigen and serum interleukin 18 and 10 in patients with locally advanced prostate cancer: a prospective study. Asian Pac J Cancer Prev. 2011;12(7):1843-8.
42. Zhu X, Ying LS, Xu SH, Zhu CH, Xie JB. Clinicopathologic and prognostic significance of serum levels of cytokines in patients with advanced serous ovarian cancer prior to surgery. Zhonghua Bing Li Xue Za Zhi. 2010;39(10):666-70.
43. Schmidt HM, Ha DM, Taylor EF, Kovach Z, Goh KL, Fock KM, et al. Variation in human genetic polymorphisms, their association with Helicobacter pylori acquisition and gastric cancer in a multi-ethnic country. J Gastroenterol Hepatol. 2011;26(12):1725-32.